Drug interactions : Avoid co-administration with drugs such as DPP-4 inhibitors
Treatment adoption has increased by 46%, supported by healthcare infrastructure expansion in 65% of urban regions
In Study A, participants receiving bremelanotide exhibited significantly greater reduction in body weight compared to placebo and reduction of mean caloric intake of approximately 400 kcal/day compared to placebo over 16 days ( Table 2 )
Retrieved June 21, 2022,from 2 Lenzi A, Lombardo F, Gandini L & Dondero F
So we have one minute left, and I'm just wondering, what does it feel like to be a researcher who's been part of what's genuinely seen as a major breakthrough, almost like a once-in-a-generation kind of breakthrough for- so many diseases